Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azimilide in patients with ICDs
NCT01464476Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Nov 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of azimilide in ventricular tachycardia (VT), ventricular fibrillation (VF), sponsored by Forest Laboratories. Started Nov 2011; status: terminated.
02
Drugs
azimilide
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)
Beyond the preview
Go deeper on NCT01464476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464476.